DANIELLE MEDVINSKY: Open Payments
NPI 1306556923 · YARDLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,141 in 49 payments from 15 companies in 2025. Trend: 2023 $1,169 · 2024 $1,790 · 2025 $1,141
Food & beverage: $1,141
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $490 |
| GlaxoSmithKline, LLC. | 19 | $262 |
| Verona Pharma, Inc. | 2 | $58 |
| Grifols USA, LLC | 2 | $53 |
| HARMONY BIOSCIENCES LLC | 1 | $49 |
| PFIZER INC. | 2 | $38 |
| ANI Pharmaceuticals, Inc. | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Vifor Pharma, Inc. | 1 | $23 |
Products named: NUCALA, BREZTRI, FASENRA, AIRSUPRA, TRELEGY ELLIPTA, Ohtuvayre, Prolastin-C Liquid, TEZSPIRE.
Industry payments across PA — which companies pay providers there.
